Javad Anjom Shoae

I completed a Master's degree in Public Health Nutrition at Tehran University of Medical Sciences, the second-ranked University in Iran, and have subsequently gained outstanding, and unique, research skills in one of the leading nutrition research teams at this university.

My skills include the performance of large epidemiological studies (I have been involved in the largest epidemiological study that has been performed on the relationship between digestive health, diet and psychological health), specialist nutritionist and dietetics expertise relevant to a number of gut disorders, and, importantly, highly specialised expertise in statistical analysis techniques required to analyse these large data sets.

Involving in different research projects led to a substantial number of peer-reviewed publications in high-impact international journals. My research experience relates to dietary assessment, and intervention, studies in people with metabolic syndrome, type 2 diabetes, breast cancer and psychological disorders, thus, together with training in nutritional sciences, clearly demonstrating a strong commitment to this field.

I commenced my PhD in August 2021 and my research will investigate whether the effects of particular nutrients, specifically the aromatic amino acids, L-tryptophan and L-phenylalanine, on energy intake and blood glucose can be further enhanced when combined with small amounts of calcium, in people with obesity and/or type 2 diabetes. Research undertaken primarily by my supervisor has established that specific GI functions have major appetite-suppressant and glucoregulatory effects and that these functions can be potently stimulated by very small amounts of specific nutrients. Therefore, based on the current concepts of how nutrients interact with GI functions in the regulation of appetite and blood glucose, and the discoveries to date, further research is required to enhance the potency of these nutrients in order to develop novel, nutrient-based strategies, which are free of side effects and cost-effective, for the prevention, and management of, obesity and its’ comorbidities (including type 2 diabetes, cardiovascular diseases and cancer), which all have adverse effects on quality of life and life expectancy and are associated with a high economic burden worldwide. Developing such strategies remains of great importance, and my research aims to make a substantial contribution.